Welten, S. M., de Jong, R. C., Wezel, A., de Vries, M. R., Boonstra, M. C., Parma, L., . . . Nossent, A. Y. (2017). Inhibition of 14q32 microRNA miR-495 reduces lesion formation, intimal hyperplasia and plasma cholesterol levels in experimental restenosis. Atherosclerosis, 261, 26-36. https://doi.org/10.1016/j.atherosclerosis.2017.04.011
Citace podle Chicago (17th ed.)Welten, Sabine M.J., et al. "Inhibition of 14q32 MicroRNA MiR-495 Reduces Lesion Formation, Intimal Hyperplasia and Plasma Cholesterol Levels in Experimental Restenosis." Atherosclerosis 261 (2017): 26-36. https://doi.org/10.1016/j.atherosclerosis.2017.04.011.
Citace podle MLA (9th ed.)Welten, Sabine M.J., et al. "Inhibition of 14q32 MicroRNA MiR-495 Reduces Lesion Formation, Intimal Hyperplasia and Plasma Cholesterol Levels in Experimental Restenosis." Atherosclerosis, vol. 261, 2017, pp. 26-36, https://doi.org/10.1016/j.atherosclerosis.2017.04.011.